Riskpilot← Back to searchSign inGet full accessRefuelBio ApS
APSActiveCVR 44960907Nordre Fasanvej 215Research and experimental development on natural sciences and engineering · NACE 7210Est. 20241 employees
Revenue 2024
DKK 0
EBITDA margin
—
Equity ratio
95.5%
Financial strength
Net profit 2024
DKK -6,2M
1 employees
| Revenue | DKK 0 | — |
| EBITDA | DKK -8M | — |
| Net profit | DKK -6,2M | — |
| Total assets | DKK 9,2M | — |
| Equity | DKK 8,8M | — |
| Employees | 1 | — |
Legal name
RefuelBio ApS
CVR number
44960907
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. juli 2024
Share capital
DKK 394.272
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med formanden for bestyrelsen eller af den samlede bestyrelse
Company purpose
Selskabets formål er forskning, udvikling og kommercialisering af medicinske produkter samt aktiviteter, der efter
ledelsens skøn er forbundet dermed.
Address
Nordre Fasanvej 215
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 0 |
| Staff expenses | -333 |
| EBITDA | -7.994 |
| Depreciation & amort. | -0 |
| EBIT | -7.994 |
| Net financials | 153 |
| Profit before tax | -7.841 |
| Tax | -1.644 |
| Net profit | -6.198 |
| Item | 2024 |
|---|---|
| Total assets | 9.161 |
| Equity | 8.751 |
| Long-term debt | 0 |
| Short-term debt | 410 |
| Total debt | 410 |
EBITDA margin
-799444100.0%
This company
15.8%
Market median
-5059772885% vs market
20242024
Equity ratio
95.5%
This company
38.2%
Market median
+150% vs market
20242024
Return on equity
-70.8%
This company
18.4%
Market median
-485% vs market
20242024
Net profit margin
-619775700.0%
This company
8.1%
Market median
-7651551952% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20242024
- Annual report 2024Filed via CVR / Virk · Period 2024-07-01 – 2024-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
TG Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novo Holdings A/S | Company | 66.7% | 66.7% | 2025 |
| Individual | 15.0% | 15.0% | 2025 | |
| Individual | 10.0% | 10.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
RefuelBio ApS Board members of RefuelBio ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Sylvester Skjærbæk | Chief Executive Officer | 0 companies |
| Thomas Gundelund Rasmussen | Chief Executive Officer | 0 companies |
| Jonathan David McNeill | Board of Directors | 0 companies |
| Satvik Dasariraju | Board of Directors | 0 companies |
| Gabor Gyulveszi | Board of Directors | 0 companies |
| Emmanuelle Coutanceau | Board of Directors | 0 companies |
| Alexander James Colville | Board of Directors | 0 companies |
| Lloyd Berl Klickstein | Chairman | 0 companies |
| Marie Allen Schroeder | Board of Directors | 0 companies |